×
About 93 results

ALLMedicine Pinta Center

Research & Reviews  45 results

SBRT in primary and metastatic liver disease: analysis after implementation in our center.
https://doi.org/10.1093/annonc/mdz155.074
Annals of Oncology : Official Journal of the European Society for Medical Oncology; De la Pinta C, Martín M et. al.

Feb 22nd, 2020 - SBRT in primary and metastatic liver disease: analysis after implementation in our center.|2020|De la Pinta C,Martín M,Sancho S,|

Rectal adenocarcinoma: clinical predictive factors for tumor response after chemoradiot...
https://doi.org/10.1093/annonc/mdz155.084
Annals of Oncology : Official Journal of the European Society for Medical Oncology; De la Pinta C, Martín M et. al.

Feb 22nd, 2020 - Rectal adenocarcinoma: clinical predictive factors for tumor response after chemoradiotherapy.|2020|De la Pinta C,Martín M,Sancho S,|

The pan-genome of Treponema pallidum reveals differences in genome plasticity between s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953169
BMC Genomics; Jaiswal AK, Tiwari S et. al.

Jan 11th, 2020 - Spirochetal organisms of the Treponema genus are responsible for causing Treponematoses. Pathogenic treponemes is a Gram-negative, motile, spirochete pathogen that causes syphilis in human. Treponema pallidum subsp. endemicum (TEN) causes endemic ...

Pinta
https://emedicine.medscape.com/article/225576-overview

Oct 28th, 2019 - Background Pinta is an endemic treponematosis caused by Treponema carateum. [1] It is an ancient disease that was first described in the 16th century in Aztec and Carib Amerindians. [2] Pinta is characterized by chronic skin lesions that occur pri...

Pinta 
https://emedicine.medscape.com/article/225576-print

Oct 28th, 2019 - Background Pinta is an endemic treponematosis caused by Treponema carateum.[1] It is an ancient disease that was first described in the 16th century in Aztec and Carib Amerindians.[2] Pinta is characterized by chronic skin lesions that occur prima...

see more →

Clinicaltrials.gov  47 results

SBRT in primary and metastatic liver disease: analysis after implementation in our center.
https://doi.org/10.1093/annonc/mdz155.074
Annals of Oncology : Official Journal of the European Society for Medical Oncology; De la Pinta C, Martín M et. al.

Feb 22nd, 2020 - SBRT in primary and metastatic liver disease: analysis after implementation in our center.|2020|De la Pinta C,Martín M,Sancho S,|

Rectal adenocarcinoma: clinical predictive factors for tumor response after chemoradiot...
https://doi.org/10.1093/annonc/mdz155.084
Annals of Oncology : Official Journal of the European Society for Medical Oncology; De la Pinta C, Martín M et. al.

Feb 22nd, 2020 - Rectal adenocarcinoma: clinical predictive factors for tumor response after chemoradiotherapy.|2020|De la Pinta C,Martín M,Sancho S,|

The pan-genome of Treponema pallidum reveals differences in genome plasticity between s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953169
BMC Genomics; Jaiswal AK, Tiwari S et. al.

Jan 11th, 2020 - Spirochetal organisms of the Treponema genus are responsible for causing Treponematoses. Pathogenic treponemes is a Gram-negative, motile, spirochete pathogen that causes syphilis in human. Treponema pallidum subsp. endemicum (TEN) causes endemic ...

Pinta
https://emedicine.medscape.com/article/225576-overview

Oct 28th, 2019 - Background Pinta is an endemic treponematosis caused by Treponema carateum. [1] It is an ancient disease that was first described in the 16th century in Aztec and Carib Amerindians. [2] Pinta is characterized by chronic skin lesions that occur pri...

Pinta 
https://emedicine.medscape.com/article/225576-print

Oct 28th, 2019 - Background Pinta is an endemic treponematosis caused by Treponema carateum.[1] It is an ancient disease that was first described in the 16th century in Aztec and Carib Amerindians.[2] Pinta is characterized by chronic skin lesions that occur prima...

see more →

News  1 results

Atara Biotherapeutics stops development of kidney drug
https://www.reuters.com/article/us-atara-study/atara-biotherapeutics-stops-development-of-kidney-drug-idUSKBN0TX17L20151214

Dec 14th, 2015 - (Reuters) - Atara Biotherapeutics Inc said it would stop developing its kidney drug after the treatment failed to meet the main goal of a mid-stage study. The drug developer said on Monday that the drug, PINTA 745, did not improve physical functio...

see more →